Psilocybin
New Study: Challenging Psychedelic Trips Lead to Positive Mental Health
The article New Study: Challenging Psychedelic Trips Lead to Positive Mental Health was originally published on Microdose.
A new study suggests that challenging…
The article New Study: Challenging Psychedelic Trips Lead to Positive Mental Health was originally published on Microdose.
A new study suggests that challenging and mystical psychedelic experiences may be connected to improved mental health outcomes.
The research was published in the Journal of Affective Disorders and reviewed survey data from almost 1,000 respondents regarding their personal experiences with psychedelics.
As reported in this article by the Ohio State News, the data suggested a connection between the intensity of mystical or insightful psychedelic experiences – and reported improvements in mental health like anxiety and depression symptoms.
The analysis also showed that challenging experiences during psychedelic trips can potentially lead to beneficial mental health results after the difficult period has passed. These patterns were observed across all psychedelic substances, including 5-MeO-DMT, Ayahuasca, LSD, mescaline, psilocybin, and peyote
See the study here.
For more like this, check out New Study Shows SSRIs Ineffective Compared to Psychedelics and Can LSD Make You Smarter? New Study Shows Positive Results
ayahuasca peyote mescaline psilocybin lsd dmt psychedelic depression anxiety research psychedelics-
LSD1 week ago
The First Wave of Blotter Acid Inspired Trippy Psychedelic Art
-
Psilocybin1 week ago
Psychedelic Underground Celebrated in San Francisco on Bicycle Day Weekend
-
Psychedelics6 days ago
Compass Pathways and Journey Clinical Establish Research Collaboration Agreement To Inform the Training of Healthcare Providers and Delivery Model for COMP360 Psilocybin Treatment, If Approved for Treatment-Resistant Depression
-
Psychedelics6 days ago
Cybin to Participate at the 27th Annual Milken Institute Global Conference
-
Psychedelics4 days ago
Freedom Biosciences Announces FDA Approval of IND Application for FREE001 in Patients with Treatment-Resistant Depression
-
Psychedelics5 days ago
Behold! A New Mushroom Emoji Has Arrived!
-
Ketamine4 days ago
DEA poised to move cannabis to Schedule III
-
Law & Regulation4 days ago
Compass Pathways, Journey Clinical to develop psilocybin treatment delivery model